Evidence map›Paper›PMID 36232415›Full record

ArticleInternational journal of molecular sciences2022

Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.

Stanislav Naryzhny, Natalia Ronzhina, Elena Zorina, Fedor Kabachenko, Nikolay Klopov, Victor Zgoda

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Proteomics and Its Applications in Cancers.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Stanislav NaryzhnyInstitute of Biomedical Chemistry, Pogodinskaya, 10, 119121 Moscow, Russia.ORCID 0000-0002-4102-3423
Natalia RonzhinaPetersburg Institute of Nuclear Physics (PNPI) of National Research Center "Kurchatov Institute", 188300 Gatchina, Russia.ORCID 0000-0001-6269-8502
Elena ZorinaInstitute of Biomedical Chemistry, Pogodinskaya, 10, 119121 Moscow, Russia.ORCID 0000-0003-4456-6850
Fedor KabachenkoInstitute of Biomedical Systems and Biotechnology, Peter the Great St. Petersburg Polytechnic University, 195251 St. Petersburg, Russia.ORCID 0000-0001-7883-1451
Nikolay KlopovPetersburg Institute of Nuclear Physics (PNPI) of National Research Center "Kurchatov Institute", 188300 Gatchina, Russia.
Victor ZgodaInstitute of Biomedical Chemistry, Pogodinskaya, 10, 119121 Moscow, Russia.
Petersburg Nuclear Physics Institute · RUInstitute of Biomedical Chemistry · RUPeter the Great St. Petersburg Polytechnic University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of tumor markers aids in the early detection of cancer recurrence and prognosis. There is a hope that they might also be useful in screening tests for the early detection of cancer. Here, the question of finding ideal tumor markers, which should be sensitive, specific, and reliable, is an acute issue. Human plasma is one of the most popular samples as it is commonly collected in the clinic and provides noninvasive, rapid analysis for any type of disease including cancer. Many efforts have been applied in searching for "ideal" tumor markers, digging very deep into plasma proteomes. The situation in this area can be improved in two ways-by attempting to find an ideal single tumor marker or by generating panels of different markers. In both cases, proteomics certainly plays a major role. There is a line of evidence that the most abundant, so-called "classical plasma proteins", may be used to generate a tumor biomarker profile. To be comprehensive these profiles should have information not only about protein levels but also proteoform distribution for each protein. Initially, the profile of these proteins in norm should be generated. In our work, we collected bibliographic information about the connection of cancers with levels of "classical plasma proteins". Additionally, we presented the proteoform profiles (2DE patterns) of these proteins in norm generated by two-dimensional electrophoresis with mass spectrometry and immunodetection. As a next step, similar profiles representing protein perturbations in plasma produced in the case of different cancers will be generated. Additionally, based on this information, different test systems can be developed.

Indexed as

NeoplasmsProteomeBiomarkers, TumorBlood ProteinsEarly Detection of CancerElectrophoresis, Gel, Two-DimensionalHumansBiomarkers, TumorBlood ProteinsProteome2DEbiomarkerpatternplasmaproteoformproteomics

Identifiers

PMID36232415
PMCPMC9569744
OpenAlexW4296627540

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.